Jenburkt Pharmaceuticals Ltd Q3 FY2024-2025 Results: Summary
Revenue | ₹38.47Cr |
Net Profits | ₹6.51Cr |
Net Profit Margins | 16.92% |
Highlights
Revenue:
Jenburkt Pharmaceuticals Ltd’s revenue jumped 3.94% since last year same period to ₹38.47Cr in the Q3 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -10.68% fall in its revenue since last 3-months.
Net Profits:
Jenburkt Pharmaceuticals Ltd’s net profit jumped 20.56% since last year same period to ₹6.51Cr in the Q3 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -32.19% fall in its net profits since last 3-months.
Net Profit Margins:
Jenburkt Pharmaceuticals Ltd’s net profit margin jumped 15.98% since last year same period to 16.92% in the Q3 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -24.08% fall in its net profit margins since last 3-months.
